This inventor holds 1 USPTO granted patent. Top assignee: Shaman Pharmaceuticals, Inc.. Active years: 1997.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1997
Title: Thomas J Carlson: Innovator in Hypoglycemic Agents
Introduction
Thomas J Carlson is a notable inventor based in Oakland, CA (US). He has made significant contributions to the field of medicine, particularly in the development of hypoglycemic agents. His work focuses on utilizing natural extracts to aid in the treatment of diabetes.
Latest Patents
Carlson holds a patent for a hypoglycemic agent derived from Cryptolepis. The patent describes the use of extracts from Cryptolepis sp. or quindoline alkaloids, such as quindoline and cryptolepine, as effective hypoglycemic agents. These extracts are particularly useful for treating both insulin-dependent (type I) and non-insulin-dependent (type II) diabetes. The preferred embodiment of his invention involves extracts derived from Cryptolepis sanguinolenta.
Career Highlights
Throughout his career, Carlson has been associated with Shaman Pharmaceuticals, Inc., where he has contributed to the advancement of pharmaceutical innovations. His work has been instrumental in exploring natural remedies for diabetes management.
Collaborations
Carlson has collaborated with various professionals in the field, including his coworker Diana M Fort. Their combined efforts have furthered research and development in hypoglycemic treatments.
Conclusion
Thomas J Carlson's innovative work in the field of hypoglycemic agents showcases the potential of natural extracts in diabetes treatment. His contributions continue to impact the medical community positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile